PBE

Invesco Biotechnology & Genome ETF · PSE

  • Category Health Care
  • Expense Ratio 0.58%
  • Listing Date Jun 23, 2005
  • Volume 12,670.0
  • Market Cap (AUM) $241.1M

Performance

+0.46%

1W

-2.55%

1M

-3.74%

3M

-7.0%

6M

-0.44%

YTD

+3.47%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • BioMarin Pharmaceutical Inc.BMRN5.59%
  • Incyte CorporationINCY5.35%
  • Regeneron Pharmaceuticals, Inc.REGN5.27%
  • Gilead Sciences, Inc.GILD5.26%
  • Vertex Pharmaceuticals IncorporatedVRTX5.18%
  • Amgen Inc.AMGN5.07%
  • Illumina, Inc.ILMN5.06%
  • Neurocrine Biosciences, Inc.NBIX4.69%
  • Halozyme Therapeutics, Inc.HALO3.16%
  • Intra-Cellular Therapies, Inc.ITCI3.09%

Technical Analysis of PBE 2025-03-17

The stock indicators present a mixed sentiment, with the Moving Average Score at 33 indicating a bearish outlook, while the Oscillators Score at 62 suggests bullish momentum. The overall Technical Score of 47 reflects a neutral stance, highlighting a potential indecision in the market despite some bullish signals from the oscillators.
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.